Clinical Oncology: Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Everolimus and Lenvatinib in a Kidney Metastatic Epithelioid Angiomyolipoma

Objective: Report the efficacy and safety of a treatment with everolimus and lenvatinib in a patient with metastatic E-AML of the kidney.

Methods: We report one case of E-AML treated at European Georges Pompidou hospital with everolimus and lenvatinib.

Results: The patient had an E-AML with pulmonary and hepatic metastases associated with somatic inactivation of TSC2. After 12 months of treatment, she demonstrated a prolonged partial response with 62% tumor shrinkage. Tolerability was manageable (grade 1 hypertension and renal failure, grade 2 diarrhea).

Conclusion: Combination of everolimus plus lenvatinib was highly effective in this case of metastatic E-AML with TSC2 inactivation. Prospective evaluation of this combination is needed.

Special Features

Full Text


Track Your Manuscript

Media Partners